You have 9 free searches left this month | for more free features.

Condition

Advanced Cancer (1)

Liposarcoma (1)

Metastatic Liposarcoma (1)

Overall Status

Active, not recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Matthew Ingham (1)

Mirati Therapeutics Inc. (1)

Collaborator

Mirati Therapeutics Inc. (1)

Intervention

mgcd516 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

mgcd516

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)

Active, not recruiting

Liposarcoma
Metastatic Liposarcoma

MGCD516

Boston, Massachusetts
+2 more

Nov 23, 2022

Advanced Cancer Trial in Korea, Republic of, United States (MGCD516)

Unknown status

Advanced Cancer

MGCD516

Birmingham, Alabama
+42 more

Jan 28, 2020